Indications and uses
Rapid, soothing, moisturizing relief of pain associated with sunburn, wind burn, blisters, and minor burns. Also reduces scar tissue, especially post-surgical.
My Pain Away After Burn Cream
- Manufacturer
- Topical BioMedics, Inc. | Ultra Seal Corporation
- Effective date
- 2016-09-26
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:22:59
Label at a glance#
ProductMy Pain Away After Burn Cream
Active ingredientARNICA MONTANA, CROTALUS HORRIDUS HORRIDUS VENOM, ECHINACEA ANGUSTIFOLIA, GRAPHITE, BELLIS PERENNIS, LACHESIS MUTA VENOM, NAJA NAJA VENOM, RUTA GRAVEOLENS FLOWERING TOP, AESCULUS HIPPOCASTANUM FLOWER, ATROPA BELLADONNA, TOXICODENDRON PUBESCENS LEAF, CALENDULA OFFICINALIS FLOWERING TOP, SULFUR, HYPERICUM PERFORATUM
Label structure7 sections
Dosage and administration
Apply generously 3-4 times daily or more often as needed, 3 inches on and around sunburn/burn area. Gently massage in until absorbed. Odorless, soothing, and moisturizing.
Label contents#
Full prescribing information#
Homeopathic Active Ingredients
Aesculus hippocastanum 6X
Arnica montana 6X
Belladona 6X
Bellis perennis 6X
Calendula officinalis 4X
Crotalus horridus 8X
Echinacea 6X
Graphites 6X
Hypericum perforatum 6X
Lachesis mutus 8X
Naja tripudians 8X
Rhus toxicodendron 12X
Ruta graveolens 6X
Sulfur 8X
Uses
Rapid, soothing, moisturizing relief of pain associated with sunburn, wind burn, blisters, and minor burns. Also reduces scar tissue, especially post-surgical.
Purpose
Warnings
For external use only. Do not apply in eyes. Keep all medicines out of reach of children. Use only as directed, an dsee a doctor if pain persists for more than 3 days, new symptoms occur, redness or swelling could indicate a more seriouos condition. Always consult a doctor before beginning a self-help regimen if you are taking prescription medicine. If swallowed, get medical help or contact a Poison Control Center right away.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Directions
Apply generously 3-4 times daily or more often as needed, 3 inches on and around sunburn/burn area. Gently massage in until absorbed. Odorless, soothing, and moisturizing.
Inactive Ingredients
Captex 300 (from coconut fatty acids), Carbopol® Ultrez 10 (from sucrose), Cetyl Alcohol (from coconut oil), Spectrastat G 2 (derived from coconut), Glycerine (vegetable-based), Hydrokote (palm kernel oil with lecithin), Isopropyl Myristate emollient (from palm seeds), Lipomulse (from coconut fatty acids), Purified Water, Sodium hydroxide, Steareth-21 (from stearic acid cocoa butter)
Other Information
Store at 15º to 30ºC (50º to 86ºF). Tamper Evident. Do not use if seal is broken or tube is open. If not completely satisfied within 30 days, return to the point of purchase with receipt for a full refund.
Principal Display Panel
NDC# 61500-0115-1
Patent Pending Formula
Homeopathic
Contains Arnica & More
MyPainAway™
AFTER BURN CREAM
SOOTHES THE PAIN AND DISCOMFORT ASSOCIATED WITH:
SUNBURN
WIND BURN
BLISTERS
MINOR BURNS
3% of all Burn Cream sales go to Burn Centers
Powered by Topricin®
Net wt. 6 oz.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61500-0115-1 | 2023-01-06 | C162847 | 48780-1 | d6a99b39-824e-a426-e053-dadaa90af4c2 | MyPainAway After Burn Cream 6oz |
| 61500-0115-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-824e-a426-e053-dadaa90af4c2 | MyPainAway After Burn Cream 6oz |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AESCULUS HIPPOCASTANUM FLOWER | ACTIVE INGREDIENT | KK0Z92II8M | 5 | |
| ARNICA MONTANA | ACTIVE INGREDIENT | O80TY208ZW | 5 | |
| ATROPA BELLADONNA | ACTIVE INGREDIENT | WQZ3G9PF0H | 5 | |
| BELLIS PERENNIS | ACTIVE INGREDIENT | 2HU33I03UY | 5 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE INGREDIENT | 18E7415PXQ | 5 | |
| CROTALUS HORRIDUS HORRIDUS VENOM | ACTIVE INGREDIENT | YHA2XLJ956 | 5 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE INGREDIENT | VB06AV5US8 | 5 | |
| GRAPHITE | ACTIVE INGREDIENT | 4QQN74LH4O | 5 | |
| HYPERICUM PERFORATUM | ACTIVE INGREDIENT | XK4IUX8MNB | 5 | |
| LACHESIS MUTA VENOM | ACTIVE INGREDIENT | VSW71SS07I | 5 | |
| NAJA NAJA VENOM | ACTIVE INGREDIENT | ZZ4AG7L7VM | 5 | |
| RUTA GRAVEOLENS FLOWERING TOP | ACTIVE INGREDIENT | N94C2U587S | 5 | |
| SULFUR | ACTIVE INGREDIENT | 70FD1KFU70 | 5 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 5 | |
| AESCULUS HIPPOCASTANUM FLOWER | ACTIVE MOIETY | KK0Z92II8M | 5 | |
| ARNICA MONTANA | ACTIVE MOIETY | O80TY208ZW | 5 | |
| ATROPA BELLADONNA | ACTIVE MOIETY | WQZ3G9PF0H | 5 | |
| BELLIS PERENNIS | ACTIVE MOIETY | 2HU33I03UY | 5 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE MOIETY | 18E7415PXQ | 5 | |
| CROTALUS HORRIDUS HORRIDUS VENOM | ACTIVE MOIETY | YHA2XLJ956 | 5 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE MOIETY | VB06AV5US8 | 5 | |
| GRAPHITE | ACTIVE MOIETY | 4QQN74LH4O | 5 | |
| HYPERICUM PERFORATUM | ACTIVE MOIETY | XK4IUX8MNB | 5 | |
| LACHESIS MUTA VENOM | ACTIVE MOIETY | VSW71SS07I | 5 | |
| NAJA NAJA VENOM | ACTIVE MOIETY | ZZ4AG7L7VM | 5 | |
| RUTA GRAVEOLENS FLOWERING TOP | ACTIVE MOIETY | N94C2U587S | 5 | |
| SULFUR | ACTIVE MOIETY | 70FD1KFU70 | 5 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 5 | |
| CAPRYLHYDROXAMIC ACID | INACTIVE INGREDIENT | UPY805K99W | 5 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 5 | |
| COCONUT ACID | INACTIVE INGREDIENT | 40U37V505D | 5 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 5 | |
| ISOPROPYL MYRISTATE | INACTIVE INGREDIENT | 0RE8K4LNJS | 5 | |
| PALM KERNEL OIL | INACTIVE INGREDIENT | B0S90M0233 | 5 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 5 | |
| STEARETH-12 | INACTIVE INGREDIENT | 51J36A59E0 | 5 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 5 |
Products#
Every source-derived product name is available through these pages.
- My Pain Away After Burn Cream
- Aesculus hippocastanum, Arnica montana, Belladonna, Crotalus horridus, Echinacea, Graphites, Heloderma, Lachesis mutus, Naja tripudians, Rhus toxicodendron, Ruta graveolens
- ARNICA MONTANA
- CROTALUS HORRIDUS HORRIDUS VENOM
- CAPRYLHYDROXAMIC ACID
- LECITHIN, SOYBEAN
- ECHINACEA ANGUSTIFOLIA
- MEDIUM-CHAIN TRIGLYCERIDES
- GRAPHITE
- GLYCERIN
- BELLIS PERENNIS
- LACHESIS MUTA VENOM
- PEG-100 STEARATE
- WATER
- NAJA NAJA VENOM
- RUTA GRAVEOLENS FLOWERING TOP
- STEARETH-21
- GLYCERYL MONOSTEARATE
- HYDROGENATED PALM KERNEL OIL
- CETYL ALCOHOL
- CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)
- SODIUM HYDROXIDE
- AESCULUS HIPPOCASTANUM FLOWER
- GLYCERYL CAPRYLATE
- ISOPROPYL MYRISTATE
- ATROPA BELLADONNA
- TOXICODENDRON PUBESCENS LEAF
- CALENDULA OFFICINALIS FLOWERING TOP
- SULFUR
- HYPERICUM PERFORATUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 61500-0115 | 61500-0115-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / ENDOTRACHEAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, COATED / ORAL | 0.08 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | OIL / AURICULAR (OTIC) | 36 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / TOPICAL | 70 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRAVENOUS | ADJ PH | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | LOTION / TOPICAL | 1140 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, EXTENDED RELEASE / ORAL | 13 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAPLEURAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER / INTRAVENOUS | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, SOLUBLE / ORAL | 11 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAVENOUS | 2.78 %w/v | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / AURICULAR (OTIC) | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / TOPICAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | ADJ PH | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / TOPICAL | 82 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAPERITONEAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / RECTAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SYRUP / ORAL | 71 mg/5ml | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVITREAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SUBCUTANEOUS | 31.45 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRADISCAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / ORAL | 9120 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRACAUDAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LOTION / TOPICAL | 21 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, EXTENDED RELEASE / ORAL | 132 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | CREAM / VAGINAL | 50 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRACAVITARY | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRAVITREAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / DENTAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / TOPICAL | 39 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL, METERED / TRANSDERMAL | 50 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / INTRAMUSCULAR | ADJ PH | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL / TOPICAL | 1.16 %w/w | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / PARENTERAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAMUSCULAR | ADJ PH |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f19b136f-84eb-5c32-e053-2a95a90a0a83 | e6285625-cc8f-4a07-8dc6-f9adc204c454 | 2023-01-06 | Warnings | e6285625-cc8f-4a07-8dc6-f9adc204c454 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.